Keyphrases
Antihypertensive Drugs
100%
Short-term Mortality
85%
Middle-aged
85%
Gastric Emptying
85%
Incretin Hormones
85%
Older Patients
85%
Emergency Department
85%
Daily Intake
85%
Risk Estimation
85%
Sympathetic Activity
85%
Laparoscopic Adjustable Gastric Banding
85%
Retrospective Cohort Study
85%
Renin-angiotensin-aldosterone System
85%
Pneumothorax
85%
Hormone Response
85%
Orally Administered
85%
Glucose Solution
85%
Nasogastric Feeding Tube
85%
Predictive Ability
85%
Feeding Tube
85%
Middle-aged Patients
61%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
36%
Area under the Curve
36%
Vital Signs
36%
Hypertension
34%
Inhibiting Effect
31%
Angiotensin-converting Enzyme Inhibitor (ACEi)
31%
Mode of Action
31%
Lactic Acid Bacteria
31%
Milk
31%
Human Studies
31%
Acetaminophen
31%
Patient Rights
28%
Plasma Noradrenaline
28%
Pressure Rate
28%
Nasogastric Tube
28%
Fatality
28%
Caucasian Women
28%
Between-group
28%
Autopsy Report
28%
Right Lung
28%
Misplacement
28%
Angiotensin-converting Enzyme Inhibition
28%
Respiratory Distress
28%
Chest X-ray
28%
Dysphagia
28%
Heart Rate
28%
Pleura
28%
Cause of Death
28%
Risk Assessment
24%
Nursing and Health Professions
Pneumothorax
85%
Gastric Banding
85%
Cohort Analysis
85%
Feeding Tube
85%
Emergency Ward
85%
Biological Marker
85%
Incretin
85%
Glucose
85%
Triage
51%
Area under the Curve
51%
Vital Sign
51%
Urokinase Receptor
51%
Tylenol
31%
Oral Glucose Tolerance Test
31%
Fatality
21%
Dysphagia
21%
Respiratory Distress
21%
Puncture
21%
Clinical Assessment
17%
Predictive Value
17%
Adverse Outcome
17%
Non Insulin Dependent Diabetes Mellitus
15%
Glucose Tolerance
15%
Agricultural and Biological Sciences
in Vivo Studies
85%
Angiotensin
85%
Fermented Milk
85%
Glucose
85%
Glucose Tolerance Test
85%
Renin
85%
Aldosterone
85%
Incretin
85%
Gastric Emptying
85%
Glucose Tolerance
42%
Blood Plasma
42%
Body Mass Index
21%
Placebo
21%
Homeostasis
21%
Impaired Glucose Tolerance
21%
Hormone Secretion
21%
Gastric Inhibitory Polypeptide
21%
Glucagon
21%
Glucagon-Like Peptide-1
21%
C-Peptide
21%
Norepinephrine
21%
Enzyme Inhibition
21%
